Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 2,100 shares, a drop of 60.4% from the May 31st total of 5,300 shares. Based on an average daily trading volume, of 1,500 shares, the days-to-cover ratio is presently 1.4 days.

Revolution Medicines Price Performance

RVMDW opened at $0.07 on Friday. The business has a 50 day simple moving average of $0.19 and a 200-day simple moving average of $0.22. Revolution Medicines has a 12 month low of $0.03 and a 12 month high of $1.05.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.